Grayscale's XRP ETF enters SEC review. Find key dates, market impact & approval chances. Stay updated on the XRP ETF process!

Wall Street faced a major sell-off, with the Dow, Nasdaq and S&P 500 all sliding. Consumer sentiment fell unexpectedly and UnitedHealth's stock dropped following a Justice Department investigation ...

The SEC reviews Grayscale’s XRP ETF filing, with a decision due by October 2025. Traders watch XRP’s price as market ...

The United States Securities and Exchange Commission (SEC) has officially approved the Grayscale bid to reclassify its XRP Trust as an ETF based on a spot exchange-traded product. NYSE Arca filed on ...

Two newly-launched cryptocurrency ETFs holding Bitcoin and Ether saw slow inflows since debuting on Feb. 14 and 20, ...

UBS Investment Bank today announced coupon payments for the ETRACS Alerian MLP Index ETN Series B (NYSE Arca: "AMUB"), traded ...

After successfully rebounding from the 2021 ATH, XRP is now well-positioned to enter its price discovery phase for the 2025 bull rally.

The SEC now has 240 days to decide on the future of XRP ETFs, with key filings posted and strong market demand for approval.

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

The Depository Trust and Clearing Corporation (DTCC) has listed Canary Capital’s spot Litecoin ETF (LTCC), a move that ...